comprehensive -WSS

comprehensive

author：hotspot 2025-09-03 15:23:45 - browse：11

Boxes of Wegovy — pharma coverage from STAT — Carsten Snejbjerg/Bloomberg

LONDON — The investment arm of Novo Nordisk’s parent foundation is buying drug manufacturer Catalent in a $16.5 billion deal, an acquisition that will give Novo additional sites as it builds up production of its booming obesity and diabetes drugs.

Under the deal, Novo Holdings is purchasing Catalent, a major contract development and manufacturing company with more than 50 sites globally. In turn, Novo Nordisk is buying three of Catalent’s fill-finish sites from the investment group for $11 billion. Novo Holdings manages the assets of the Novo Nordisk Foundation, which has a controlling stake in the pharmaceutical company.

Catalent has been involved in the production of Novo’s obesity treatment Wegovy. With the agreement, Novo will pick up sites that focus on filling drugs in Italy, Brussels, and Bloomington, Ind. All have already been doing work for Novo.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： Bubonic plague hit France in 1720. Officials dithered. Sound familiar?

hotspot

WSS

Ozempic cut risk of death in diabetes patients with chronic kidney disease

340B reform proposal comes out of Senate working group

Lawsuit challenges CMS nursing home minimum staffing rule

Why some fertility treatments produce more boy babies

Unique patient identifier: Experts argue the benefits, pitfalls

Medicare Advantage plans can’t deny care with AI, CMS warns

hotspot

comprehensive

hotspot

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Louisiana bill approved classifying abortion pills as controlled substances

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Cano Health’s bankruptcy is a warning for Medicare Advantage

Drug repurposing or repositioning? The language matters

The HPV vaccine prevents cancer in men, too. Why do so few people get it?

Medical leaders decry Supreme Court decision on affirmative action

A single Democrat is willing to weaken Medicare negotiation power

DIEP, the 'gold standard' of breast reconstruction, is under threat

Beyond aggravation: Constipation is an American epidemic

hotspot

Achieving telehealth equity for people with hearing loss

340B reform proposal comes out of Senate working group

Readout Newsletter: Amgen, Regeneron, BGI Group and more

The CDC's new social media misinformation war

Top private equity targets in 2023: cardiology, clinical trials, lasers

340B reform proposal comes out of Senate working group

hotspot

hotspot

entertainment

focus